Society for Immunotherapy of Cancer, Milwaukee, WI, USA.
J Transl Med. 2011 Jan 31;9:18. doi: 10.1186/1479-5876-9-18.
The Society for Immunotherapy of Cancer, SITC (formerly the International Society for Biological Therapy of Cancer, iSBTc), aims to improve cancer patient outcomes by advancing the science, development and application of biological therapy and immunotherapy. The society and its educational programs have become premier destinations for interaction and innovation in the cancer biologics community. For over a decade, the society has offered the Primer on Tumor Immunology and Biological Therapy of Cancer™ in conjunction with its Annual Scientific Meeting. This report summarizes the 2010 Primer that took place October 1, 2010 in Washington, D.C. as part of the educational offerings associated with the society's 25th anniversary. The target audience was basic and clinical investigators from academia, industry and regulatory agencies, and included clinicians, post-doctoral fellows, students, and allied health professionals. Attendees were provided a review of basic immunology and educated on the current status and most recent advances in tumor immunology and clinical/translational cancer immunology. Ten prominent investigators presented on the following topics: innate immunity and inflammation; an overview of adaptive immunity; dendritic cells; tumor microenvironment; regulatory immune cells; immune monitoring; cytokines in cancer immunotherapy; immune modulating antibodies; cancer vaccines; and adoptive T cell therapy. Presentation slides, a Primer webinar and additional program information are available online on the society's website.
癌症免疫治疗学会（SITC，前身为国际癌症生物治疗学会，iSBTc）的宗旨是通过推进癌症生物疗法和免疫疗法的科学、发展和应用，改善癌症患者的预后。该学会及其教育计划已成为癌症生物制品界互动和创新的主要场所。十多年来，该学会一直在其年度科学会议上联合提供《肿瘤免疫学与癌症生物疗法基础》。本报告总结了 2010 年 10 月 1 日在华盛顿特区举行的 2010 年基础版，作为与学会 25 周年相关的教育活动的一部分。目标受众是来自学术界、工业界和监管机构的基础和临床研究人员，包括临床医生、博士后研究员、学生和相关健康专业人员。与会者将了解基础免疫学，并了解肿瘤免疫学和临床/转化癌症免疫学的最新现状和最新进展。十位杰出的研究人员就以下主题进行了演讲：先天免疫和炎症；适应性免疫概述；树突状细胞；肿瘤微环境；调节性免疫细胞；免疫监测；癌症免疫疗法中的细胞因子；免疫调节抗体；癌症疫苗；和过继性 T 细胞疗法。演示幻灯片、基础版网络研讨会和其他计划信息可在学会网站上在线获取。
